🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to evaluate whether selinexor combined w...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-13
Trial ID
NCT07743957
Treatments Being Tested
This study will evaluate the safety, tolerability, pharmacokinetics, and ac...
Status
Completed
Location
Royal Adelaide Hospital
Start Date
2022-04-28
Trial ID
NCT05243342
Treatments Being Tested
The main purpose of this study is to see how well a new treatment ramantami...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-22
Trial ID
NCT07665450
Treatments Being Tested
Multiple myeloma (MM) accounts for more than 10% of all blood cancers and 1...
Status
Terminated
Location
Sylvester Comprehensive Cancer Center /ID# 228817
Start Date
2022-01-17
Trial ID
NCT04895410
Treatments Being Tested
A single-arm study utilizing a 6 x 4 expansion design using daratumumab SC ...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center
Start Date
2022-03-21
Trial ID
NCT05004259
Treatments Being Tested
This is an open-label, multicenter, Phase 2 study in subjects with newly di...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-06-15
Trial ID
NCT06418477
Treatments Being Tested
Amyloid light chain (AL) amyloidosis is a rare disease caused by abnormal p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11-29
Trial ID
NCT07793422
Multiple myeloma (MM) is a plasma cell disease characterized by the growth ...
Status
Recruiting
Location
University of Southern California /ID# 272414
Start Date
2025-07-23
Trial ID
NCT06953960
Treatments Being Tested
The purpose of this study is to compare the efficacy of daratumumab in comb...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-16
Trial ID
NCT02252172
Treatments Being Tested
The purpose of this study is to test whether Daratumumab-SC, a drug that el...
Status
Completed
Location
Stanford Health Care
Start Date
2021-07-01
Trial ID
NCT04610320
Treatments Being Tested